ICICI Prudential Healthcare Fund
- NAV as on 9 Nov 2026
- ₹44.43+2.11%1 day
- Return since launch
- 19.5%
- 52-week range
- ₹36.38 — ₹44.28
- AUM
- ₹7,104 Cr
ICICI Prudential Healthcare Fund is a Sectoral-Pharma equity fund from ICICI Prudential Mutual Fund with ₹7,104 Cr under management, launched in 2018. Over three years it has returned 13.9% a year, against 21.2% for its category. The expense ratio is 2.06% and the SEBI riskometer reading is Very High.
Performance
ICICI Prudential Healthcare Fund NAV and returns
Growth of the fund against its category average over the period you pick.
Over 1Y this fund returned +10.7% against +19.4% for its category.
Performance
Returns
How the fund has done against its category and its benchmark.
| Period | Fund | vs category | Category | Benchmark |
|---|---|---|---|---|
| 1Y | 18.0% | −2.8 pts | 20.8% | 29.1% |
| 2Y | 12.2% | −6.9 pts | 19.1% | 17.6% |
| 3Y | 13.9% | −7.3 pts | 21.2% | 16.0% |
| 5Y | 19.6% | +4.2 pts | 15.4% | 18.5% |
| 7Y | 19.8% | +0.9 pts | 18.9% | 18.0% |
| Period | Fund | vs category | Category | Benchmark |
|---|---|---|---|---|
| 1M | 7.4% | −1.0 pts | 8.4% | 8.5% |
| 3M | 1.2% | −2.5 pts | 3.7% | 3.7% |
| 6M | 6.9% | −7.1 pts | 14.0% | 13.6% |
| 1Y | 10.7% | −10.1 pts | 20.8% | 19.4% |
| 2Y | 7.5% | −3.4 pts | 10.8% | 9.5% |
| 3Y | 21.3% | 0.0 pts | 21.2% | 20.0% |
| 5Y | 16.6% | +1.2 pts | 15.4% | 14.6% |
| 7Y | 23.7% | +1.4 pts | 22.4% | 21.2% |
Since launch (25 Jun 2018): 19.5%
Calendar-year returns
Category averageShow as a table
| Period | Fund | vs category | Category |
|---|---|---|---|
| 2025 | -0.8% | +1.2 pts | -2.0% |
| 2024 | 47.7% | +6.8 pts | 40.9% |
| 2023 | 41.3% | +5.1 pts | 36.2% |
| 2022 | -8.5% | −0.2 pts | -8.3% |
| 2021 | 18.2% | −3.5 pts | 21.7% |
| 2020 | 71.4% | +2.6 pts | 68.8% |
Returns over one year are annualised. Shorter periods are absolute.
Costs & terms
Costs and terms
What the fund charges each year, and the rules around putting money in and taking it out.
Costs
2.05%
Expense ratio as on 5 Nov 2026
Charged yearly and already deducted from the NAV.
- Base expense
- 1.54%
- Brokerage
- 0.06%
- Transaction charges
- 0.01%
- Statutory levies
- 0.44%
- Exit load
- Exit load of 1% if redeemed within 15 days.
- Lock-in
- None
Terms
- Min SIP
- ₹3,000
- Min lumpsum
- ₹5,000
- Plan
- GROWTH
- Fund type
- OPEN-ENDED
- Benchmark
- BSE Healthcare TRI
- Short-term capital gains
- Returns taxed at 20% if you redeem before 1 year
- Long-term capital gains
- After 1 year, returns above ₹1.25 lakh in a financial year are taxed at 12.5%
Risk
Risk
What the riskometer means for this fund, and how its ratios sit against the category.
Your principal is treated as being at very high risk — typically small cap, sectoral and thematic equity schemes.
| Ratio | Fund | Category avg | Read as |
|---|---|---|---|
| Alpha | -0.83 | 1.49 | Return earned above what the benchmark alone would have given. Higher is better. |
| Beta | 0.96 | 0.94 | How hard the fund moves when the market moves. Under 1 is steadier than the market. |
| Sharpe | 0.95 | 1.10 | Return earned for each unit of total risk taken. Higher is better. |
| Sortino | 1.40 | 1.81 | Return earned for each unit of downside risk. Higher is better. |
| Std. deviation | 16.16 | 15.62 | How widely monthly returns have varied around their own average. Lower is steadier. |
| Average of 5 category peers | |||
Portfolio
ICICI Prudential Healthcare Fund portfolio
Portfolio as of 30 Sep 2026
Asset allocation
- Equity98.9%
- Other1.1%
Market cap split
- Large23.6%
- Mid33.2%
- Small43.2%
- P/E
- 39.70
- P/B
- 4.01
Top holdings
| Holding | Sector | Weight | Value | 3M chg | 6M chg | 1Y chg |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | 11.49% | ₹788 Cr | +12.20% | +12.11% | +11.58% |
| Dr. Reddy's Laboratories Ltd. | Healthcare | 9.73% | ₹668 Cr | +8.22% | +5.97% | +9.10% |
| Cipla Ltd. | Healthcare | 5.79% | ₹397 Cr | +6.67% | +9.23% | +6.92% |
| Biocon Ltd. | Healthcare | 5.33% | ₹366 Cr | +2.59% | +6.08% | +3.11% |
| Mankind Pharma Ltd. | Healthcare | 5.04% | ₹346 Cr | +6.98% | +7.01% | +2.95% |
| Alkem Laboratories Ltd. | Healthcare | 4.81% | ₹330 Cr | +5.67% | +3.52% | +4.05% |
| Medplus Health Services Ltd. | Healthcare | 4.31% | ₹296 Cr | +3.66% | +2.73% | +1.14% |
| Cohance Lifesciences Ltd. | Healthcare | 4.06% | ₹278 Cr | +4.31% | +3.18% | +1.64% |
| Divi's Laboratories Ltd. | Healthcare | 3.78% | ₹259 Cr | +5.57% | +5.91% | +8.75% |
| Syngene International Ltd. | Healthcare | 3.50% | ₹240 Cr | +2.89% | +3.52% | +2.21% |
| Dr. Agarwal's Health Care Ltd. | Healthcare | 2.66% | ₹182 Cr | — | — | — |
| Max Healthcare Institute Ltd. | Healthcare | 2.63% | ₹181 Cr | +3.10% | — | — |
| Abbott India Ltd. | Healthcare | 2.54% | ₹175 Cr | +2.47% | — | — |
| Alembic Pharmaceuticals Ltd. | Healthcare | 2.50% | ₹171 Cr | +2.58% | +1.62% | +1.70% |
| Pfizer Ltd. | Healthcare | 2.42% | ₹166 Cr | +1.86% | +1.35% | +1.46% |
| Apollo Hospitals Enterprise Ltd. | Healthcare | 2.30% | ₹158 Cr | — | — | — |
| Gland Pharma Ltd. | Healthcare | 1.97% | ₹135 Cr | — | +1.55% | +2.97% |
| Akums Drugs And Pharmaceuticals Ltd. | Healthcare | 1.91% | ₹131 Cr | +2.05% | +1.83% | — |
| Lupin Ltd. | Healthcare | 1.88% | ₹129 Cr | +2.30% | +4.09% | +5.43% |
| Astrazeneca Pharma India Ltd. | Healthcare | 1.85% | ₹127 Cr | +0.82% | +0.72% | +0.80% |
| Blue Jet Healthcare Ltd. | Healthcare | 1.83% | ₹126 Cr | +1.51% | +1.13% | +1.14% |
| Indegene Ltd. | Healthcare | 1.74% | ₹119 Cr | — | — | — |
| Metropolis Healthcare Ltd. | Healthcare | 1.65% | ₹113 Cr | +1.42% | +1.26% | +1.43% |
| Rainbow Children's Medicare Ltd. | Healthcare | 1.29% | ₹88.55 Cr | +1.44% | — | — |
| Fine Organic Industries Ltd. | Chemicals | 1.21% | ₹82.86 Cr | +1.33% | +1.06% | +1.08% |
| Thyrocare Technologies Ltd. | Healthcare | 1.17% | ₹80.16 Cr | +2.24% | +1.74% | +1.39% |
| Aarti Drugs Ltd. | Healthcare | 1.17% | ₹79.96 Cr | +1.06% | +0.93% | +1.19% |
| Others | Others | 1.09% | ₹75.07 Cr | +0.02% | +0.02% | +0.40% |
| Medi Assist Healthcare Services Ltd. | Services | 1.06% | ₹72.77 Cr | +1.33% | +1.14% | +1.81% |
| Alivus Life Sciences Ltd | Healthcare | 0.97% | ₹66.27 Cr | +1.54% | +2.44% | — |
| Hikal Ltd. | Healthcare | 0.95% | ₹64.87 Cr | +1.34% | +0.93% | +0.44% |
| Sanofi Consumer Healthcare India Ltd. | Healthcare | 0.93% | ₹64.08 Cr | +1.14% | +0.98% | +0.80% |
| Manipal Health Enterprises Ltd. | Healthcare | 0.87% | ₹59.96 Cr | — | — | — |
| Entero Healthcare Solutions Ltd. | Healthcare | 0.74% | ₹50.92 Cr | +1.69% | +1.90% | — |
| Laxmi Dental Ltd. | Healthcare | 0.68% | ₹46.50 Cr | +0.77% | +0.56% | +0.84% |
| FDC Ltd. | Healthcare | 0.66% | ₹45.57 Cr | +0.78% | +0.62% | +0.85% |
| Windlas Biotech Ltd. | Healthcare | 0.57% | ₹38.86 Cr | +0.78% | +1.00% | +1.25% |
| Indraprastha Medical Corporation Ltd. | Healthcare | 0.47% | ₹32.07 Cr | — | — | — |
| Indoco Remedies Ltd. | Healthcare | 0.43% | ₹29.35 Cr | +0.60% | — | — |
| Natco Pharma Ltd. | Healthcare | 0.02% | ₹1.36 Cr | — | — | — |
Sectors
Instruments
Recent changes
| Holding | From | To | Weight |
|---|---|---|---|
| Apollo Hospitals Enterprise Ltd. | 0.00% | 2.30% | +2.30% |
| Gland Pharma Ltd. | 0.00% | 1.97% | +1.97% |
| Dr. Reddy's Laboratories Ltd. | 8.26% | 9.73% | +1.47% |
| Divi's Laboratories Ltd. | 4.83% | 3.78% | -1.05% |
| Sun Pharmaceutical Industries Ltd. | 12.31% | 11.49% | -0.82% |
| Biocon Ltd. | 4.68% | 5.33% | +0.65% |
| Pfizer Ltd. | 1.86% | 2.42% | +0.57% |
| Entero Healthcare Solutions Ltd. | 1.23% | 0.74% | -0.49% |
| Indraprastha Medical Corporation Ltd. | 0.00% | 0.47% | +0.47% |
| Alivus Life Sciences Ltd | 1.21% | 0.97% | -0.24% |
| Syngene International Ltd. | 3.29% | 3.50% | +0.21% |
| Indegene Ltd. | 1.92% | 1.74% | -0.18% |
| Mankind Pharma Ltd. | 5.21% | 5.04% | -0.17% |
| Abbott India Ltd. | 2.38% | 2.54% | +0.17% |
| Medplus Health Services Ltd. | 4.15% | 4.31% | +0.16% |
| Indoco Remedies Ltd. | 0.58% | 0.43% | -0.15% |
| Astrazeneca Pharma India Ltd. | 1.99% | 1.85% | -0.14% |
| Dr. Agarwal's Health Care Ltd. | 2.79% | 2.66% | -0.13% |
| Thyrocare Technologies Ltd. | 1.30% | 1.17% | -0.13% |
| Hikal Ltd. | 1.05% | 0.95% | -0.10% |
| Blue Jet Healthcare Ltd. | 1.93% | 1.83% | -0.10% |
| Metropolis Healthcare Ltd. | 1.74% | 1.65% | -0.09% |
| Akums Drugs And Pharmaceuticals Ltd. | 1.99% | 1.91% | -0.08% |
| Lupin Ltd. | 1.96% | 1.88% | -0.08% |
| Medi Assist Healthcare Services Ltd. | 1.13% | 1.06% | -0.07% |
| Rainbow Children's Medicare Ltd. | 1.36% | 1.29% | -0.07% |
| Aarti Drugs Ltd. | 1.10% | 1.17% | +0.07% |
| Alkem Laboratories Ltd. | 4.87% | 4.81% | -0.06% |
| Manipal Health Enterprises Ltd. | 0.92% | 0.87% | -0.05% |
| FDC Ltd. | 0.62% | 0.66% | +0.05% |
| Sanofi Consumer Healthcare India Ltd. | 0.97% | 0.93% | -0.04% |
| Max Healthcare Institute Ltd. | 2.59% | 2.63% | +0.04% |
| Cohance Lifesciences Ltd. | 4.08% | 4.06% | -0.03% |
| Cipla Ltd. | 5.76% | 5.79% | +0.03% |
| Alembic Pharmaceuticals Ltd. | 2.48% | 2.50% | +0.02% |
| Natco Pharma Ltd. | 0.00% | 0.02% | +0.02% |
| Fine Organic Industries Ltd. | 1.22% | 1.21% | -0.01% |
| Laxmi Dental Ltd. | 0.67% | 0.68% | +0.01% |
| Windlas Biotech Ltd. | 0.57% | 0.57% | -0.01% |
| Others | 0.01% | 0.01% | 0.00% |
Compare
Similar funds
The rest of the category, so this fund’s numbers have something to sit against.
| Fund | AUM | Expense | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| Category average | ₹2,934 Cr | 1.89% | 36.5% | 20.8% | 21.6% |
| ₹6,067 Cr | 1.98% | 35.0% | 19.9% | 22.6% | |
| ₹3,501 Cr | 2.11% | 39.6% | 25.8% | — | |
| ₹3,494 Cr | 2.01% | 37.3% | 20.2% | 21.1% | |
| ₹1,430 Cr | 2.21% | 30.6% | 18.4% | 21.1% | |
| ₹177 Cr | 1.13% | 39.9% | 19.9% | — |
About
About this fund
The scheme’s own words, its benchmark and the people running it.
Investment objective
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Fund managers
- Dharmesh KakkadMr. kakkad is B.com., CA & CFA.He is associated with ICICI Prudential Asset Management Company Limited from June 2010. Prior to working in Dealing function, he was working in the Operations Department of ICICI Prudential AMC.
Tools
Return calculator
What ₹10,000 a month in this fund would have grown to over each period, based on its past returns.
| Over the past | Total investment | Would’ve become | Growth | Returns |
|---|---|---|---|---|
| 6 months6.91% absolute | ₹60,000 | ₹64,146 | 6.91% | |
| 1 year10.69% annualised | ₹1,20,000 | ₹1,27,181 | 5.98% | |
| 3 years21.27% annualised | ₹3,60,000 | ₹5,06,612 | 40.73% | |
| 5 years16.64% annualised | ₹6,00,000 | ₹9,39,396 | 56.57% |
Returns for 1 year and longer are annualised (CAGR); 6-month figures are absolute. Past returns are not a forecast.
How this is calculated
Each monthly instalment grows at the fund’s annualised return ÷ 12 per month until the end of the period, the same formula as our SIP calculator.
The amount compounds once a year at the fund’s CAGR for that period, the same formula as our lumpsum calculator.
Questions
Frequently asked questions
The things people ask about this scheme.